KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Non-Current Deferred Tax Liability (2018 - 2023)

Historic Non-Current Deferred Tax Liability for Vir Biotechnology (VIR) over the last 6 years, with Q1 2023 value amounting to $3.3 million.

  • Vir Biotechnology's Non-Current Deferred Tax Liability fell 8235.8% to $3.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $3.3 million, marking a year-over-year decrease of 8235.8%. This contributed to the annual value of $3.3 million for FY2022, which is 8235.8% down from last year.
  • Per Vir Biotechnology's latest filing, its Non-Current Deferred Tax Liability stood at $3.3 million for Q1 2023, which was down 8235.8% from $3.3 million recorded in Q4 2022.
  • In the past 5 years, Vir Biotechnology's Non-Current Deferred Tax Liability ranged from a high of $18.4 million in Q4 2021 and a low of $3.3 million during Q4 2020
  • In the last 5 years, Vir Biotechnology's Non-Current Deferred Tax Liability had a median value of $3.3 million in 2019 and averaged $7.3 million.
  • As far as peak fluctuations go, Vir Biotechnology's Non-Current Deferred Tax Liability surged by 46683.06% in 2021, and later plummeted by 8235.8% in 2022.
  • Vir Biotechnology's Non-Current Deferred Tax Liability (Quarter) stood at $3.3 million in 2019, then decreased by 1.57% to $3.3 million in 2020, then skyrocketed by 466.83% to $18.4 million in 2021, then tumbled by 82.36% to $3.3 million in 2022, then changed by 0.0% to $3.3 million in 2023.
  • Its Non-Current Deferred Tax Liability was $3.3 million in Q1 2023, compared to $3.3 million in Q4 2022 and $18.4 million in Q3 2022.